Article
A SARS-CoV-2 nucleocapsid protein TR-FRET assay amenable to high-throughput screening
2021-07-05
Abstract excerpt
Drug development for specific antiviral agents against coronavirus disease 2019 (COVID-19) is still an unmet medical need as the pandemic continues to spread globally. Although huge efforts for drug repurposing and compound screens have put forth, only few compounds remain in late stage clinical trials. New approaches and assays are needed to accelerate COVID-19 drug discovery and development. Here we report a tim...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f495b01b-9e2b-504f-a080-f0d435ccc418
- DOI
- 10.1101/2021.07.03.450938
